Company News

ZURICH, Switzerland, May 2024 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation […]

ZURICH, Switzerland, December 2023 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation […]

Zurich, Switzerland, December 2023 – Venture Valuation announces that it has appointed Bill Colihan and […]

Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business […]

Media Release Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business […]

ZURICH, Switzerland, May 2023 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation […]